The Role of Steroids and Hormones in Gynecomastia-Factors and Treatments

Abstract

Gynecomastia is an endocrine disorder where the male breast tissue swells and growth in the size abnormally. All men and women have breast glands; however they're no longer significant in males, because they have a tendency to be small and undeveloped. Drugs which include steroids motive 10%-25% of cases of gynecomastia. They throw off the hormonal stability which increases in estrogen (the female sex hormone) and/or a lower in testosterone (the male sex hormone), which reasons the breast tissue to develop. Almost all reasons of gynecomastia may be in a single manner or different much like excess production of the hormone estrogen inside the male frame because of different factors. In this article, we overview the reasons and treatment of gynecomastia.

Full text

The Role of Steroids and Hormones in Gynecomastia-Factors and
Treatments
Pooja Shree*
Department of Biotechnology, SSIET-Anna University, Chennai, India
*Corresponding author: Pooja Shree, Department of Biotechnology, SSIET-Anna University, Chennai, India, E-mail: Shrithushree@gmail.com
Received date: September 21, 2018; Accepted date: October 5, 2018; Published date: October 12, 2018
Copyright: ©2018 Shree P. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original author and source are credited
Abstract
Gynecomastia is an endocrine disorder where the male breast tissue swells and growth in the size abnormally. All
men and women have breast glands; however they're no longer significant in males, because they have a tendency
to be small and undeveloped. Drugs which include steroids motive 10%-25% of cases of gynecomastia. They throw
off the hormonal stability which increases in estrogen (the female sex hormone) and/or a lower in testosterone (the
male sex hormone), which reasons the breast tissue to develop. Almost all reasons of gynecomastia may be in a
single manner or different much like excess production of the hormone estrogen inside the male frame because of
different factors. In this article, we overview the reasons and treatment of gynecomastia.
Keywords: Estrogen; Gynecomastia; Steroids; Breast tissue
Introduction
Gynecomastia is a benign growth of the male breast tissue. Gynae
which means “lady” and mastos means “breast” in Greek. It can be
characterized as the nearness of >2 cm of palpable, rm and ductal
breast tissue. Before digging profound into the reasons for
gynecomastia, let's get straight about what is gynecomastia and what it
isn't. Breast enlargement in male caused by inordinate bosom tissue
development is authentic gynecomastia. Breast enlargement in men
can likewise be caused by fat being developed behind and around the
areola and this is to be recognized from pseudogynecomastia or
adipomastia or lipomastia. is is to be prominent from
pseudogynecomastia, which lacks presence of this sort of disk of tissue,
as it is a boom in sub areolar fat without growth of the breast glandular
aspect [1-3].
Gynecomastia is found in 60%–90% of newborns and commonly
resolves spontaneously within few weeks. Most pubertal young men
create gynecomastia, by the age of 14 years 60% of boys have
gynecomastia. Beyond the pubertal age, gynecomastia is found in
33%-41% ordinary men matured 25-45 years and in 55%-60% of men
over the age of 50 years (Figure 1).
Figure 1: Swollen male breast tissue caused by a hormone
imbalance.
Gynecomastia pathophysiology
e imbalance between estrogen actions relative to androgen action
at the breast tissue level appears to be the main etiology of
gynecomastia.
Depending on the hormonal conditions within the body, any
demanding elements, and other issues will determine the rate of
progression within the improvement of gynecomastia and the depth
and severity of the formation of breast tissue include: e sort of
anabolic steroid(s) utilized, measurements of anabolic steroids utilized,
span of utilization of the anabolic steroids, and perhaps the most
critical persuasive deciding component, personal individual hereditary
qualities and responsiveness [4,5].
Steroidal abuse
Steroid clients are one of the sub bunches among men who have
gynecomastia. e un-methodical utilization of it is the thing that
causes gynecomastia. When a steroid client begins his cycle, the
regular hormonal adjust in his body is changed by concealment of the
creation of the male hormone testosterone. is triggers a progression
of chain response coming full circle in the improvement of
gynecomastia.
Not all steroids prompt Gynecomastia, but rather they all have their
consequences. Anadrol and Dianabol are large reasons for
Gynecomastia, yet there are others. Estrogen goes about as the
essential oender in the arrangement and the advancement of gyno
where it will append to the Estrogen receptors situated on cells inside
breast tissue and signal growth. What comes about is then a
continuous improvement of greasy tissue, stringy tissue, and glandular
tissue that inevitably aer some time will detail full Gynecomastia
[6-11].
Hormonal imbalance
All individuals regardless own both female sex hormones
(estrogens) and male sex hormones (androgens). During pubescence,
levels of these hormones may change and ascend at various levels,
J
o
u
r
n
a
l
o
f
S
t
e
r
o
i
d
s
&
H
o
r
m
o
n
a
l
S
c
i
e
n
c
e
ISSN: 2157-7536
Journal of Steroids & Hormonal
Science
Shree, J Steroids Horm Sci 2018, 9:2
DOI: 10.4172/2157-7536.1000195
Review Article Open Access
J Steroids Horm Sci, an open access journal
ISSN: 2157-7536
Volume 9 • Issue 2 • 1000195

bringing about a transitory state in which estrogen xation is
tremendously high. Gynecomastia caused by temporary adjustments in
hormone tiers with increase usually disappears on its own within six
months to 2 years. Occasionally, gynecomastia that develops in
pubescence holds on past two years and is called persistent pubertal
gynecomastia [12-14].
Low testosterone levels
Illegal testosterone medications utilized for building up can cause
breast development in males. Anabolic steroids are manufactured
synthetic variants of testosterone. While testosterone treatment can
assist enhance your sexual coexistence, muscle mass, vitality,
disposition and it could also purpose some transient breast
development. is is on account of all men have an enzyme called
aromatase that converts testosterone to a shape of estrogen. Taking a
medication to hinder the transformation of testosterone to estrogen
additionally is certiably not a smart thought [15-18].
High estrogen levels
e female sex hormone estrogen inside the male may cause the
breast development. It may be over abundance estrogen persisted from
pubescence, due to a pre-current medical circumstance, as a reaction
of medicines or because of drug abuse. Once there is an abundance of
estrogen, it sets o a sequence response with the aid of decreasing the
generation of testosterone and bringing down digestion. Abundance
estrogen will likewise signal the body to hold more fat in the chest and
in the belly. When fat is stored in the chest and belly, they emit a
catalyst called aromatase that converts testosterone to estrogen. So
pectoral fat basically turns into an auxiliary organ that produces
estrogen [19-21].
Medical Conditions that Can Cause Gynecomastia
Around 20% of gynecomastia is caused by medications or
exogenous chemicals. Drugs and chemicals that cause decreased
testosterone levels either by causing direct testicular damage, by
blocking testosterone synthesis, or by blocking androgen action can
produce gynecomastia. For instance, phenothrin, a chemical
component in delousing agents, possessing antiandrogenic activity, has
been attributed as the cause of an epidemic of gynaecomastia among
Haitian refugees in US detention centers in 1981 and 1982.
Chemotherapeutic drugs, such as alkylating agents, cause Leydig cell
and germ cell damage, resulting in primary hypogonadism.
One of the traditional examples of a scientic condition that
motives gynecomastia is Klinefelter Syndrome. is disorder is
described by a chromosomal oddity with men having an extra X
chromosome. Studies have demonstrated that men with this medicinal
condition have gynecomastia as a typical side eect [22-24].
Hyperthyroidism
e thyroid organ is in charge of the creation of thyroid hormones
and hyperthyroidism takes place when this gland turns over-energetic.
Hyperthyroidism is sexually unbiased and can happen to the two
people yet in men, it is considered as one of the reasons of
gynecomastia. Early recognition of this condition and auspicious
intercession has been located to eectively reverse gynecomastia
[25,26].
Kidney failure
Kidney failure is one of the medicinal conditions that can cause
gynecomastia when our kidneys can't do their ordinary siing process,
it triggers a progression of bodily reactions and hormonal brokenness
is one among them. e nal product is a concealment of the
generation of Testosterone. In this situation, estrogen levels tip the
hormonal stability inicting gynecomastia.
Treatment and Medication
Treatment of Gynecomastia is not constantly important. It relies on
its motive, period, and severity and whether it causes agony or
uneasiness. Since early stages of gynecomastia happens in puberty
stage, normally resolves on its very own without treatment within three
years in 90% of cases, no active remedy is needed. But if the breast
increases >4 cm in measurement may not be reduced totally. If
medicines are the reason for gynecomastia, halting the culpable
medication can be eective in decreasing gynecomastia. Treatment of
any basic therapeutic conditions is likewise imperative. Both
pharmaceuticals and surgical procedures have been eectively used to
treat gynecomastia [27-29].
Once gynecomastia is established, testosterone treatment of
hypogonadal men with gynecomastia oen fails to produce breast
regression. Unfortunately, testosterone treatment may actually produce
the side eect of gynecomastia by being aromatized to estradiol. us,
although testosterone is used to treat hypogonadism, its use to
specically counteract gynecomastia is limited. Dihydrotestosterone, a
non-aromatizable androgen, has been used in patients with prolonged
pubertal gynecomastia with good response rates.
From previous series, the patients with gynecomastia show no
signicant improvement aer the medications. is may be related to
the stage of disease at which medical treatment is initiated. It has been
suggested that the patient with a long history of gynecomastia, in
which the breast tissue becomes brotic, tends to be resistant to
medical treatment.
Breast surgery
Reduction mammoplasty is taken into consideration for patients
with macromastia or long-status gynecomastia or in persons in whom
medical therapy has failed. Minimally invasive surgery is available and
it may be associated with few complications and prompt recovery.
It is also considered for beauty reasons. e aims of surgery are: (1)
to get rid of painful breast tissue. (2) To restore the patient's chest to
acceptable beauty form. Complications of surgical procedure consist of
removal of tissue because of a compromised blood supply, contour
irregularity, hematoma or sarcoma formation, and everlasting
numbness inside the nipple-areolar place, doughnut deformity, nipple
necrosis, nipple attening [30].
Liposuction
is surgical procedure removes breast fats, but no longer the breast
gland tissue itself. Liposuction/lipoplasty (“fat modeling”) is best
remedy as it is associated with few sequelae. In this technique, a limited
cannula is embedded in breast tissue and used to vacuum fat tissue
aer that cannula pushed and pulled to break all adipocytes and
suctioning them out. is method is known as suction-helped
liposuction [31,32].
Citation: Shree P (2018) The Role of Steroids and Hormones in Gynecomastia-Factors and Treatments. J Steroids Horm Sci 9: 195. doi:
10.4172/2157-7536.1000195
Page 2 of 4
J Steroids Horm Sci, an open access journal
ISSN: 2157-7536
Volume 9 • Issue 2 • 1000195

Mastectomy
e commonly utilized method is subcutaneous mastectomy that
includes coordinate resection of the glandular tissue utilizing a peri-
areolar or trans-areolar approach, with or without liposuction.
Liposuction alone might be adequate if bosom growth is absolutely
because of overabundance greasy tissue without considerable glandular
hypertrophy. is less invasive sort of surgical operation entails much
less recovery time [33].
Selective estrogen receptor modulators (SERMs)
SERMs are tamoxifen and raloxifene can help reduce the amount of
breast tissue, even though they are not ready to completely dispense
with the issue [34]. Tamoxifen, an estrogen antagonist, is eective for
recent-onset and gentle gynecomastia Up to 80% of patients report
partial to nish resolution. ese medicinal drugs are most oen used
for excessive or painful gynecomastia With the management of
clomiphene, an antiestrogen about 50% of suerers acquire partial
diminishment in breast size, and approximately 20% of patients
observe entire resolution. Adverse outcomes are uncommon and
consist of visual problems, rashes, and nausea. Other capsules used,
albeit less oen, includes danazol [35]. Danazol, a synthetic subsidiary
of testosterone, inhibits pituitary secretion of LH and follicle-
stimulating hormone (FSH), which decreases estrogen synthesis from
the testicles [36].
Radiotherapy
Radiation therapy is compelling for counteractive action, and
treatment of gynecomastia, caused by androgen ablation in suerers of
prostate tumor. Radiation treatment is more successful if given
prophylactically before administration of hormone therapy. However,
it has been utilized with some achievement in overseeing painful
gynecomastia [37].
Discussion
Gynecomastia associated with medicinal conditions can be
counteracted by using appropriate therapeutic interventions or
via
avoidance of the incriminated agent. When age-associated hormonal
uctuations result in gynecomastia, it isn't avoidable prophylactically
[38]. When administering lengthy-time period hormonal remedy to
prostate most cancer suerers, prophylactic irradiation of bilateral
breasts can save you subsequent development of gynecomastia [27].
Making intelligent lifestyle choices oers the best option for
preventing gynecomastia not associated with an underlying disorder.
Various factors have been tied to imbalances in hormones. Body
builders should avoid anabolic steroids that disturb hormone
production and cause other health problems [39]. Use of marijuana has
been connected with increased levels of estrogen. Proper diet and
exercise can reduce the risk of pseudogynecomastia, the buildup of fat
tissue. Prevention of gynecomastia caused by other therapies or
underlying disorders may be possible with medications that reduce the
eect those factors have on male and female hormones [40].
Conclusion
Treatments for gynecomastia have now not been drastically studied,
No tablets have yet been permitted by using the U.S. Food and Drug
Administration for remedy of gynecomastia. Fortunately, in lots of
instances, gynecomastia resolves spontaneously without the want for
unique remedy. Medical and surgical remedies can be eective for
continual gynecomastia. Typically gynecomastia is itself not
threatening; however guys with gynecomastia have an improved
hazard (approximately ve-fold) for growing male breast cancer when
as compared with the general population. It is possibly that the
hormonal adjustments that produce gynecomastia in male additionally
boom their danger of developing breast most cancers. is is a
commonly identied entity and consciousness to diagnose and
attention to analyze and treat it properly is justied.
References
1. Yordanov YP, Shef A (2017) Acute tissue trauma as a trigger for
gynecomastia development and progression. J Trauma Treat 6: 409.
2. Sankaranantham M (2017) Hypogonadism and gynecomastia in 3
adolescent boys on ART- 3. HIV Curr Res 2: 123.
3. Bhattacharya SK (2016) Gynecomastia in a young male. J Mol Imag
Dynamic 6: 106.
4. Campos PMR, Rosa BP, Barros AS, Karmali S, Almeida JF, et al. (2017) A
rare case of bilateral patellar tendon rupture associated with anabolic
androgenic steroids use. Orthop Muscular Syst 6: 238.
5. Nuzzi R, Dallorto L (2017) Ecacy and safety of combined intravitreal
bevacizumab and retrobulbar corticosteroids for neovascular age-related
macular degeneration. J Clin Exp Ophthalmol 8: 659.
6. Somani S, Meghani S (2016) Substance abuse among youth: a harsh
reality. Emerg Med (Los Angel) 6: 330.
7. Giardino PA (2016) Child abuse and neglect: Are cases increasing or
decreasing aer 50+ years of paediatric attention? Clinics Mother Child
Health 13: 235.
8. Linder JM, Silverstone PH (2016) Initial long-term ndings from a
multimodal treatment program for child sexual abuse victims
demonstrate reduction of ptsd frequency and symptoms. J Child Adolesc
Behav 4: 297.
9. Ahmadi J (2016) Conduct disorder related to poly substance abuse in
adolescence. J Psychiatry 19: 371.
10. Raiker N, Aouthmany M, Ezra N (2016) Dermatologic signs and
symptoms of substance abuse. J Clin Exp Dermatol Res 7: 337
11. Carmen M Sarabia-Cobo (2016) Screening and interventions in elderly
abuse. Glob J Nurs Forensic Stud 1: e104.
12. Onwubuya EI, Ukibe NR, Kalu OA, Agbo BS, Ukibe SN, et al. (2018)
Assessment of the eects of oxidative stress on some reproductive
hormones in male hypertensive subjects at nauth, nnewi. J Bioanal
Biomed 10: 64-69.
13. Kelleni MT (2017) Diabetogenic drugs and hormones, what every
physician should know and be aware of ? Gen Med (Los Angeles) 5: e114.
14. Ginneken VV, Ham L, de Vries E, Verheij E, van der Greef J, et al. (2016)
Comparison of hormones, lipoproteins and substrates in blood plasma in
a c57bl6 mouse strain aer starvation and a high fat diet: A metabolomics
approach. Anat Physiol 6: 233.
15. Azad N, Sakla N, Bahn G (2018) e eect of testosterone replacement
therapy on glycemic control in hypogonadal men with type 2 diabetes
mellitus. J Clin Diabetes 1: 101.
16. Hadlow N, Hamilton K, Joseph J, Millar D, Zentner A, et al. (2017)
Relationships between anti-mullerian hormone, testosterone, luteinizing
hormone and follicle stimulating hormone in men on testosterone
therapy. Clin Med Biochem 3: 128.
17. Ueshiba H (2017) e ecacy of testosterone ointment on insulin
resistance in men with metabolic syndrome. J Metabolic Synd 6: 225.
18. Gunnels TA, Bloomer RJ (2014) Increasing circulating testosterone:
impact of herbal dietary supplements. J Plant Biochem Physiol 2: 130.
19. Zhang K (2014) Epigenetic reprogramming induced by environmental
estrogens. Mol Biol 3: e115.
Citation: Shree P (2018) The Role of Steroids and Hormones in Gynecomastia-Factors and Treatments. J Steroids Horm Sci 9: 195. doi:
10.4172/2157-7536.1000195
Page 3 of 4
J Steroids Horm Sci, an open access journal
ISSN: 2157-7536
Volume 9 • Issue 2 • 1000195

20. Bazin I, Hassine AIH, Mnif W, Gonzalez C (2013) YES as a tool for
detecting estrogenic activity of some food additives compounds: E 104, E
122, E 124, E 132 and E 171. J Ecosys Ecograph 3: 128.
21. Suba Z (2013) Low estrogen exposure and/or defective estrogen signaling
induces disturbances in glucose uptake and energy expenditure. J
Diabetes Metab 4: 272.
22. https://www.mayoclinic.org/diseases-conditions/gynecomastia/
symptoms-causes/syc-20351793
23. https://www.gynecoma.com/gynecomastia-diagnosis-treatment/
24. Väre T, Galassi FM, Niinimäki J, Junno JA (2018) Potential case of
gynecomastia in mummied remains of an early modern period
northern nnish vicar. Clin Anat 31: 641-644.
25. Arya R, Rathi AK, Singh K, Srivastava A, Panda D, et al. (2016)
Gynecomastia: A review of literature. MAMC J Med Sci 2: 69-75.
26. Al Jurayyan NA (2016) Childhood gynecomastia: a mini review. Int J Clin
Endocrinol Metab 2: 012-015.
27. Cuhaci N, Burcak Polat S, Evranos B, Ersoy R, Cakir B (2014)
Gynecomastia: Clinical evaluation and management. Indian J Endocrinol
Metab 18: 150-158.
28. Arvind A, Abbas Khan MA, Srinivasan K, Roberts J (2014)
Gynaecomastia correction: A review of our experience. Indian J Plast
Surg 47: 56-60.
29. Narula H, Carlson H (2014) Gynaecomastia- pathophysiology, diagnosis
and treatment. Nat Rev Endocrinol 10: 684-698.
30. Mangla M, Singla D (2017) Gestational gigantomastia: A systematic
review of case reports. J Midlife Health 8: 40-44.
31. Moskovitz MJ, Baxt SA, Jain AK, Hausman RE (2007) Liposuction breast
reduction: a prospective trial in african american women. Plast Reconstr
Surg 119: 718-726.
32. Bellini E, Grieco MP, Raposio E (2017) A journey through liposuction
and liposculture: Review. Ann Med Surg (Lond) 24: 53-60.
33. Lazaraviciute G, Chaturvedi S (2017) Mastectomy-a critical review. J Clin
Diagn 7: 58-66.
34. Maximov PY, Lee TM, Jordan VC (2013) e discovery and development
of selective estrogen receptor modulators (serms) for clinical practice.
Curr Clin Pharmacol 8: 135–155.
35. Goodsell DS (2002) e molecular perspective: tamoxifen and the
estrogen receptor. e Oncol 7: 163-164.
36. Dmowski WP (1990) Danazol, a synthetic steroid with diverse biologic
eects. J Reprod Med 35: 69-74.
37. Luh JY, Harmon MW (2010) Radiation therapy for gynecomastia. Mayo
Clin Proc 85: 398-399.
38. Johnson RE, Murad HM (2009) Gynecomastia: Pathophysiology,
evaluation, and management. Mayo Clin Proc 84: 1010-1015.
39. Sansone A, Romanelli F, Sansone M, Lenzi A, Di Luigi L (2017)
Gynecomastia and hormones. Endocrine 55: 37-44
40. Carlson HE (2011)Approach to the patient with gynecomastia. J Clin
Endocrinol Metab 96: 15-21.
Citation: Shree P (2018) The Role of Steroids and Hormones in Gynecomastia-Factors and Treatments. J Steroids Horm Sci 9: 195. doi:
10.4172/2157-7536.1000195
Page 4 of 4
J Steroids Horm Sci, an open access journal
ISSN: 2157-7536
Volume 9 • Issue 2 • 1000195